Latest Antisense news

Latest Antisense
News & Updates.

1 year ago

Dosing commenced in DMD combination therapy study

1 year ago

Sharecafe Webinar – ATL1102 for DMD: Revised Clinical Study Plans

1 year ago

Mark Diamond Interview with Jane King

1 year ago

ATL1102 for DMD: Revised Clinical Development Plans Presentation

1 year ago

ATL1102 for DMD: Revised Clinical Development Plans accelerate reporting of unblinded data

1 year ago

Appendix 4E & Full Statutory Accounts

1 year ago

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

1 year ago

ATL1102 for DMD Clinical Trial Application Submitted in Europe

1 year ago

New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2

1 year ago

Presentation at 2nd Annual Oligonucleotide for CNS Summit

2 years ago

Investor Presentation

2 years ago

Quarterly Activities/Appendix 4C